Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket
Update: Summit Therapeutics Closes Phase 3 Lung Cancer Study Enrollment, Gets FDA Fast Track; Shares up Premarket
更新:峯會生物關閉第3期肺癌研究招募,獲FDA快速通道;盤前股價上漲
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊